2017-18 GSK Influenza Vaccines
Prebooking is now available for GSK Influenza Vaccines. Pre-booking is available until March 31, 2017. Highlights are listed below. Please contact us for more information
FLULAVAL QUADRIVALENT (Multi-Dose Vials)
1 Pricing does not include Federal Excise Tax (FET) of $0.75 per dose. Price is per dose, not per 10 pack unit.
All formulations of Havrix Adult, both pre-filled syringes and vials, are out of stock until May 2017. Twinrix vial and PFS presentations are available for order. To help manage the backorder process, GSK will turn off the ability to order Havrix Adult Prefilled Syringe and Vial presentations.
GSK currently has a limited supply of RabAvert in their distribution centers. Due to delays in the manufacturing process, RabAvert resupply dates have been pushed out from January 2017 to March 2017.
In an effort to manage existing inventory, GSK will continue to accept new orders for RabAvert, however these orders will be placed on backorder until resupply is received. GSK does have a limited supply of RabAvert in inventory and can make product available to physicians who are not able to order through a wholesaler/distributor and who need RabAvert for post-exposure prophylaxis in an emergency situation.
GSK believes that there is sufficient inventory in the W/D channels to meet market demand, however, when GSK has low supply or is out of stock, wholesalers and distributors often allocate available product to their customers due to GSK's backorder. The wholesalers' and distributors' allocation approach can vary and may be based on customer's historical demand.
2017-2018 GSK Influenza Vaccines
Havrix Adult is out of stock until May 2017
Rabavert supply is limited